PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services

Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

MINDCURE Announces Additional Equity Investment in ATMA

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division

Newscope Announces Name Change

Revive Provides Dial-In Information for Annual and Special Meeting

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

Greg McKee | CEO, Tryp Therapeutics

Core One Labs Vocan Expands Product Commercialization Team

NeonMind Developing Music Playlist for Psychedelic Therapy Sessions

Algernon Pharmaceuticals Announces Appointment of Global Expert Dr. Steven L. Wolf for DMT Stroke Program

Entheon Biomedical Corp. Launches HaluGen's Psychedelics Genetic Test

Lobe Sciences Appoints Ilan Hayman to Advisory Board

Optimi Health Aims to Expand its Shareholder Base

MindMed Announces the Publication of New Data on Personalized MDMA Dosing